P95

Koning Leopold Iii-Laan 1

3001 Leuven

BE

P95

Foundation date

17/06/2011

Sector

#Biotechnology / R&D Services

Subsector

At P95, we find, collect, analyse and report epidemiological data to assist public health agencies, research organisations and pharmaceutical companies in improving peoples´ access to safe and effective medicines.

Upcoming events

Latest news

  • argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis

    Thursday September 21st 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023